本页面由Tiger Trade Technology Pte. Ltd.提供服务

Milestone Pharmaceuticals Inc.

0.8055
+0.04055.29%
成交量:117.27万
成交额:92.79万
市值:9,988.20万
市盈率:-1.19
高:0.8141
开:0.7800
低:0.7400
收:0.7650
52周最高:3.06
52周最低:0.7075
股本:1.24亿
流通股本:1.06亿
量比:0.98
换手率:1.10%
股息:- -
股息率:- -
每股收益(TTM):-0.6748
每股收益(LYR):-0.7517
净资产收益率:-35522.62%
总资产收益率:-42.78%
市净率:5.48
市盈率(LYR):-1.07

数据加载中...

2023/03/10

重要事件披露

8-K - Current report
2023/03/07

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/18

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/06

重要事件披露

8-K - Current report
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/10

重要事件披露

8-K - Current report
2022/10/31

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/24

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/17

重要事件披露

8-K - Current report
2022/09/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/10

重要事件披露

8-K - Current report
2022/07/08

重要事件披露

8-K - Current report
2022/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]